by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective
by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective
byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-
byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-
Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica
Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica
byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize
byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize
by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim
by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b
by Sonya Goins, Mayo Clinic News NetworkHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaDealing with chronic conditions like Crohn
by Sonya Goins, Mayo Clinic News NetworkHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaDealing with chronic conditions like Crohn
by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,
by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,